{
  "recommendations": [
    "Initiate hemodynamic stabilization with fluid resuscitation and/or vasopressors to achieve SBP >90 mmHg and MAP >65 mmHg prior to contrast administration.",
    "Administer a reduced contrast volume of 0.8-1.0 mL/kg (approximately 50-70 mL) using low-osmolar or iso-osmolar iodinated contrast.",
    "Implement a comprehensive renal protection protocol including pre- and post-hydration with isotonic saline.",
    "Consider a Ventilation-Perfusion (V/Q) scan if hemodynamic goals cannot be met or the patient remains unstable."
  ],
  "rationale": [
    "Patient is hypotensive (MAP 59 mmHg), increasing risk of contrast-induced renal injury and necessitating hemodynamic stabilization.",
    "Elevated creatinine (1.7 mg/dL) and eGFR of 59 mL/min/1.73m² indicate moderate renal impairment, requiring reduced contrast dose.",
    "Missing weight and height prevent precise weight-based contrast dosing and BMI calculation, necessitating an estimated range.",
    "ACR guidelines advise caution with contrast in hypotensive and renally impaired patients, recommending hydration and dose adjustment."
  ],
  "protocol_selection": [
    {
      "protocol_id": "CT_CHEST_ANGIO_PULMONARY_EMBOLISM",
      "name": "CT Pulmonary Angiography (Chest CTA for PE)",
      "indications": [
        "pulmonary embolism",
        "acute chest pain",
        "shortness of breath"
      ],
      "description": "CT angiography timed for pulmonary arterial phase (6–13 sec post-contrast) to evaluate pulmonary arteries for embolism. Modified contrast volume and hydration protocols are required.",
      "contrast_timing": "Pulmonary arterial phase: ~6–13 sec post-injection.",
      "contrast_dose": "Modified weight-based; ~0.8–1.0 mL/kg (approx. 50–70 mL) iodinated contrast (300 mg I/mL); follow ACR Manual and institutional guidelines for renal impairment and hypotension.",
      "renal_safety_notes": "Requires pre-hydration, reduced contrast volume, and post-hydration. Hemodynamic stabilization is mandatory prior to contrast administration. eGFR of 59 mL/min/1.73m² and hypotension are significant risk factors.",
      "references": [
        "Contrast CT phases overview (Wikipedia):contentReference[oaicite:0]{index=0}",
        "CT pulmonary angiogram practical notes (Wikipedia):contentReference[oaicite:1]{index=1}"
      ]
    },
    {
      "protocol_id": "V/Q_SCAN",
      "name": "Ventilation-Perfusion (V/Q) Scan",
      "indications": [
        "pulmonary embolism",
        "alternative to CTPA in renal impairment",
        "alternative to CTPA in contrast allergy",
        "alternative to CTPA in pregnancy"
      ],
      "description": "Radiopharmaceutical study to assess for pulmonary embolism by imaging ventilation and perfusion in the lungs. Preferred modality for patients with significant contraindications to iodinated contrast agents.",
      "contrast_timing": "N/A (radiopharmaceutical administered).",
      "contrast_dose": "N/A.",
      "renal_safety_notes": "No iodinated contrast is used, making it a safe alternative for patients with renal impairment or hypotension where contrast-enhanced CT is contraindicated or high-risk.",
      "references": [
        "V/Q scan procedure (RadiologyInfo):contentReference[oaicite:10]{index=10}"
      ]
    }
  ]
}